Just been browsing through Replicors website and if you look at the pipeline information it says follow ups should have been complete by Q1 2019 See link
http://replicor.com/pipeline/
We are long passed that anybody know whats actually going on?
Good question, I also wonder. On the internet all the papers show data for the patients that have chb with delta virus. I don't know if ever replicor will be used for chb without delta.